We are live on ! Find out more
IRD

Opus Genetics
IRD

20 hedge funds and large institutions have $804K invested in Opus Genetics in 2013 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$347K +$279K +1,628 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$108K +$86.8K +506 New
Bank of New York Mellon
3
Bank of New York Mellon
New York
$68K +$54.8K +319 New
Nomura Holdings
4
Nomura Holdings
Japan
$49K +$39.5K +230 New
Northern Trust
5
Northern Trust
Illinois
$43K +$34.8K +203 New
BMC
6
Benin Management Corp
Connecticut
$37K +$29.7K +173 New
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$24K +$19.1K +111 New
Bank of America
8
Bank of America
North Carolina
$22K +$17.9K +104 New
Goldman Sachs
9
Goldman Sachs
New York
$18K +$14.4K +84 New
GC
10
Guggenheim Capital
Illinois
$17K +$14.1K +82 New
State Street
11
State Street
Massachusetts
$16K +$12.9K +75 New
Citadel Advisors
12
Citadel Advisors
Florida
$13K +$10.3K +60 New
WA
13
WFG Advisors
Texas
$9K +$7.21K +42 New
BA
14
BlackRock Advisors
Delaware
$8K +$6.18K +36 New
KCG
15
Knight Capital Group
$7K +$5.49K +32 New
CS
16
Credit Suisse
Switzerland
$7K +$6.01K +35 New
U
17
UBS
Switzerland
$6K +$4.81K +28 New
Citigroup
18
Citigroup
New York
$3K +$2.57K +15 New
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K +$858 +5 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$1K +$858 +5 New

IRD Hedge Fund Activity: Q2 2013 in Review

20 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2013, worth a combined $804K.

Buyers outnumbered sellers: 20 funds opened new IRD positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

  • 20 institutional investors held Opus Genetics (IRD) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $804K of Opus Genetics stock for Q2 2013.
  • 20 funds opened new Opus Genetics positions in Q2 2013 and 0 closed out, a net change of +20 holders.

Based on aggregated 13F filings for Q2 2013.